CYAD Market Cap History
Below is a table of the CYAD market cap history going back to 8/9/2019:

Date CYAD Market Cap
8/9/201987.10M

Also see: CYAD Shares Outstanding History
and CYAD YTD Return
Mouse over chart for data details
8/9/2019
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. Co.'s primary product candidates include: CYAD-101, which is an investigational, non-gene edited, allogeneic CAR T candidate engineered to co-express a CAR based on natural killer group 2D ligands, a receptor expressed on natural killer cells that binds to eight stress-induced ligands and T cell receptor inhibitory molecule; and CYAD-211, which is an investigational, short hairpin RNA-based allogeneic CAR T candidate for the treatment of relapsed / refractory multiple myeloma. We show 1 historical shares outstanding datapoints in our CYAD shares outstanding history coverage, used to compute CYAD market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CYAD market cap history over the course of time is important for investors interested in comparing CYAD's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CYAD versus a peer is one thing; comparing CYAD market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CYAD can fluctuate over the course of history. With this page we aim to empower investors researching CYAD by allowing them to research the CYAD market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CYAD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Celyad SA (CYAD) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CYBR Market Cap History
CYRN Market Cap History
DADA Market Cap History
DALI Market Cap History
DALS Market Cap History
DAPP Market Cap History
DAT Market Cap History
DAVA Market Cap History
DAVE Market Cap History
DAX Market Cap History
More Miscellaneous companies »

 

CYAD Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2023, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.